Enumerix

Enumerix

Biotechnology

Palo Alto, California 1,082 followers

Next-generation PCR

About us

In an era of ever-increasing cost and skills required to do complex diagnostics tests, Enumerix is developing a next-generation genomics platform to make high resolution biology simple, fast, and affordable. Our goal is to reduce the cost of high resolution tests by at least 10 times to enable access to a broader patient population. We believe our team is poised to accomplish this. We are a group of seasoned biotech and innovative entrepreneurs, engineers, and scientists with a proven track record of advancing the field of genomics from innovation to commercial success. We have pioneered DNA microarrays, non-invasive prenatal screening using next generation sequencing (NGS), and high-throughput single-cell NGS, and together the founding team holds over 60 granted patents.

Industry
Biotechnology
Company size
11-50 employees
Headquarters
Palo Alto, California
Type
Privately Held
Founded
2019

Locations

Employees at Enumerix

Updates

Similar pages